Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Zair Tovar Noguera"'
Autor:
Zair Tovar Noguera, Ibell Oropeza Ceija, Luis Arturo Gutierrez-Gonzalez, Marialina Marin Leonet, Marco Antonio Rivera Gudiño
Publikováno v:
The Open Rheumatology Journal
Objectives:Our aim was to compare an AntiCD20 therapy (rituximab) for rheumatoid arthritis in two patient populations (Group 1), anti-TNFα naïve patients and inadequate responders to Anti-TNFα therapy (Group 2).Methods:We analyzed the efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8cb0d0d82d3438d6f3111f9061279c6
https://doi.org/10.2174/1874312920130913004
https://doi.org/10.2174/1874312920130913004
Autor:
Mayra Rauseo, Zair Tovar Noguera, Eugenia Benzaquen, Rafael Montaño, Luis Antonio Mundarain, Eduardo Puertas-Abreu, José Gregorio Rivas, Luis Arturo Gutiérrez González, Freddy Herrera Vivas, Elaudi Rodríguez Polanco, Eduardo Toro, Omar Bellorin, Concepción Morelia Nuñez-Sotelo, Francisco Marín, Miriam Azocar
Publikováno v:
International Archives of Medicine
International Archives of Medicine, Vol 5, Iss 1, p 7 (2012)
International Archives of Medicine, Vol 5, Iss 1, p 7 (2012)
Background The anti-TNFα therapy has been since its approval by the FDA, along with nonsteroidal antiinflammatory drugs (NSAIDs), one of the most important therapies for control of spondyloarthritis (SpA). The onset of Lupus Like Syndrome (LLS) has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec9eae2b6c6a307978dd6b14da78c44c
http://europepmc.org/articles/PMC3295660
http://europepmc.org/articles/PMC3295660